EnCureGen
Latest round
- Seed
Last raised
- Jun 2023
Total raised
- Undisclosed
Investors
- 4
About EnCureGen
Based in Guangzhou, China, and founded in 2023, EnCureGen operates as a biotechnology company that focuses on the development of innovative mRNA drugs. The founder of the company, Aimin Hui, worked as the CEO of Fosun Pharmaceutical. EnCureGen is engaged in the development of innovative mRNA drugs for oncology and immunology as well as vaccines for infectious diseases. The company also builds the technology platform for mRNA.
Who invested in EnCureGen
4 investors across 1 round
See all investors in EnCureGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 8, 2023
Amount
Undisclosed
Investors
Questions about EnCureGen
Who invested in EnCureGen?
EnCureGen has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EnCureGen raised?
EnCureGen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EnCureGen last raise money?
EnCureGen's most recent round on record is a Seed, in Jun 2023.
What does EnCureGen do?
Based in Guangzhou, China, and founded in 2023, EnCureGen operates as a biotechnology company that focuses on the development of innovative mRNA drugs.
Where is EnCureGen headquartered?
EnCureGen is headquartered in Guangzhou, China.
Which VCs invest in companies like EnCureGen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at EnCureGen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like EnCureGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.